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Abstract
Background: We investigated the impact and the predictive value of sinus rhythm at 12 months (SR12) on
subscales of three different HrQoL questionnaires: SF-36., EuroQoL and MFI 20.
Methods: Data of 125 cardiac surgery patients with pre-operative AF from our previous randomized trial were
used. Based on their rhythm outcome patients were divided in two groups: SR12 or AF at 12 months follow up
(non-SR12). All questionnaires were self-administered pre-operatively and at 3 months, 6 months and 12 months
after surgery.
Results: Synus rhytm at 12 months was predictive of improvement of SF36- mental score (MS, p = 0.021), Euro-QoL-MS
(p = 0.009), VAS (p = 0.006), and MFI 20-MS (p = 0.009). We failed to find any significant interactions between SR12 and
any of the other significant risk factors: age <65 years, paroxysmal type of AF and preoperative AF duration
<12 months. In contrast, SR12 was not significant in predicting physical score (PS) subscales of any of the
questionnaires (all, p > 0.05) which were predicted by age <65 years (SF36-PS, p = 0.029) by paroxysmal type of AF and
age <65 years (Euro-QoL-PS, p = 0.017 and p = 0.04, respectively) and by AF duration <12 months, paroxysmal type of
AF and age < 65 years (MFI 20-PS, p = 0.019, p = 0.020 and p = 0.015, respectively).
Conclusions: Specific mental-related HrQoL scales are much more sensitive to sinus rhythm conversion. Sinus rithm
mantainance shows significant effects on mental scores independently of other cofactors. Successful conversion to
sinus rhythm after surgical ablation during cardiac surgery does not significantly affect phisical health related quality of
life during 1 year follow up.
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Background
Atrial fibrillation (AF) is the most common cardiac
rhythm disorder seen in the clinical practice accounting
for approximately one-third of hospitalizations or car-
diac rhythm disturbance [1].
Health-related quality of life (HrQoL) of patients with
AF has been reported to significantly worsen, therefore
enhancing HrQoL has gradually been established as one
of the most important target when treating patients with
AF [2]. Indeed, HrQoL has been shown to improve fol-
lowing medical theraphy and transcatheter ablation [3,
4]. In addition, it has beed demonstrated that conversion
to sinus rhythm by surgical ablation during other cardiac
surgery procedures (add-on surgery) can significantly
improve the health-related quality of life [5, 6].
Nonetheless, concerns remain regarding whether this
improvement in HrQoL is affected more by the treat-
ment of the underlying heart disease than by the restor-
ation of sinus rhythm (SR) since the relationship
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Table 1 Demographic Data (n = 125)
Study population SR12-group (N = 62) Non-SR12-group (N = 63) p-value
Age (Years) 67.9 ± 8.9 67.4 (39.0–84.0) 68.4 (46.0–81.0) .38
Weight (Kg) 79.2 ± 17.0 78.6 (49–170) 79.7 (53–111) .73
Gender (male) 79 (63.2 %) 42 (66.7 %) 37 (59.7 %) .42
Civil state .16
Divorced 8 (6.5 %) 7 (11.1 %) 1 (1.6 %)
Married 84 (87.7 %) 42 (66.7 %) 42 (68.9 %)
Unmarried with partner 10 (8.1 %) 5 (7.9 %) 5 (8.2 %) 0.16
Widow(er) 22 (17.7 %) 9 (14.3 %) 13 (21.3 %)
Education
Primary school 27 (22.0 %) 11 (17.5 %) 16 (26.7 %)
Lower education 30 (24.4 %) 15 (23.8 %) 15 (25.0 %) .52
Intermediate education 45 (36.6 %) 24 (38.1 %) 21 (35.0 %)
High education 21 (17.1 %) 13 (20.6 %) 8 (13.3 %)
Previous cardiac history
Atrial Fibrillation:
Paroxysmal AF 54 (43.2 %) 37 (58.7 %) 17 (27.4 %)
Permanent AF 41 (32.8 %) 11 (17.5 %) 30 (48.4 %) < .01
Persistent AF 28 (22.4 %) 13 (20.6 %) 15 (24.2 %)
Atrial flutter 2 (1.6 %) 2 (3.2 %) 0 (0 %)
Total months of AF 82.0 ± 104.8 67.9 (3–403) 96.9 (3–617) .03
Left Atrial Dimension (mm) 50.6 ± 7.4 48.7 (33–65) 53.3 (40–70) <.01
Left Ventrical Ejection Fraction (%) 52.6 ± 13.5 53.2 (18–80) 51.9 (22–75) .68
Co-morbidity/Riskfactors (N = 122)
Hypertension 51 (41.8 %) 25 (40.3 %) 26 (43.3 %) .74
Stroke 6 (4.9 %) 2 (3.2 %) 4 (6.7 %) .38
Smoking: .50
Never 56 (46.3 %) 30 (48.4 %) 26 (44.1 %)
Current 16 (13.2 %) 6 (9.4 %) 10 (16.9 %)
Past 49 (40.5 %) 26 (41.9 %) 23 (39.0 %)
Positive Family History 61 (49.2 %) 27 (42.9 %) 34 (55.7 %) .15
Diabetes 18 (14.8 %) 13 (21.0 %) 5 (8.3 %) .05
Renal Disease 7 (5.6 %) 3 (4.8 %) 4 (6.5 %) .68
COPD 20 (16.3 %) 8 (12.7 %) 12 (20.0 %) .27
Previous myocardial infarction 31 (24.8 %) 19 (30.2 %) 12 (19.4 %) .16
Cardiomyopathy 21 (17.1 %) 10 (16.1 %) 11 (18.0 %) .78
Congenital Heart disease 7 (5.7 %) 2 (3.2 %) 5 (8.3 %) .22
Systolic Blood Pressure (mmHg) 141.9 ± 26.6 144.7 (70–200) 139.3 (80–190) .28
Diastolic Blood Pressure (mmHg) 79.4 ± 17.8 82.3 (40–180) 76.5 (40–110) .18
Pre-operative complaints (N = 123)
Palpitations 51 (41.5 %) 28 (45.2 %) 23 (37.7 %) .40
Dyspnea 98 (79.7 %) 48 (77.4 %) 50 (82.0 %) .53
Angina 49 (40.2 %) 24 (39.3 %) 25 (41.0 %) .85
(Pre-) Syncope 7 (5.7 %) 3 (4.8 %) 4 (6.6 %) .68
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between conversion to SR and HrQoL has not been
rigorously tested.
Therefore the present study was aimed at investigating
the relationship between successful SR conversion and
1-year postoperative HrQoL after add-on surgery meas-
uring the impact and the predictive value of SR12 on
subscales of three different HrQoL questionnaires: SF-
36., EuroQoL and MFI 20.
Methods
Study population
Pre- and postoperative clinical data were used from the
patients enrolled in the ASAF trial [7]. Based on their
rhythm outcome patients were divided in two groups:
SR at 12 months follow up (SR12) or AF at 12 months
follow up (non-SR12). Antiarrhythmic and anticoagulant
protocols were as previously reported [7]. Patients were
seen at the outpatient clinic 3 months, 6 months, and
12 months after the surgical procedure, and annually
thereafter. All subjects reached 12-month follow-up. At
each follow-up visit, patients underwent an electrocar-
diogram and, at the 12-month appointment, all patients
had a 24-h Holter.
Quality of life questionnaires
For HrQoL assessment both generic- and disease-
specific questionnaires were used.
The RAND 36-item Health Survey 1.0 (SF-36) dis-
plays 8 multi-item scales (Body Pain, BP; General
Health, GH, Mental Health, MH; Phisical Functioning
PF; Role Emotional, RE, Role Phisical,RP; Social Func-
tioning, SF; Vitality Vt). Each domain comprises a 5-
point Likert scale ranging from 1 (bad perceived
health) to 5 (excellent perceived health) [8]. SF-36
also assesses 2 major health concepts, physical and
mental, with 2 composite scores, the physical com-
posite score (PCS) and the mental composite score
(MCS). The physical scales (Physical Functioning,
Role Physical, Bodily Pain, and General Health) make
up the PCS, and the remaining 4 scales (Mental
Health, Role Emotional, Vitality, and Social Function-
ing) make up the MCS. Reliability by the test–retest6
between baseline and at follow-up was good, with in-
terclass correlation coefficients ranging between 0.75
and 0.88. Internal consistency [9] was good for the 8
scales, with Cronbach coefficients ranging between
0.86 and 0.93.
The EuroQoL is a self-report questionnaire that con-
sists of 2 parts- EQ-VAS (visual analogue scale of 0 to
100 for recording an individuals’ rating of their current
health-related QoL state), and the three-level, five-
dimensional descriptive system (EQ-5D), which evalu-
ates mobility (M), self-care (SC), usual activities (UA),
pain/discomfort (P/D) and anxiety/depression (A/D) on
a 0 to 100 scale using the European value set [10].
The Multidimensional Fatigue Inventory (MFI-20)
consists of 5 scales of fatigue (General Fatigue, GF; Men-
tal Fatigue, MF; Phisical Fatigue, MF; Reduced Activities,
RA, Reduced Motivation, RM) with scores ranging from
‘definitely tired’ to ‘definitely not tired’ on a 5-point
Likert scale [11].
All questionnaires were self-administered pre-
operatively and at 3 months, 6 months and 12 months
after surgery.
Statistical analysis
The power analysis was determined by Graph Pad
Stat Mate software, release 2.00 (Graph Pad Prism
Software, Inc, San Diego, CA) on the basis of the
following assumption: type I error of 0.05 (two-sided)
and difference in 12-month SF-36-mental health of
3.4. The calculated statistical power was 0.85 with a
sample size per group of 62. Continuous data were
expressed as mean ± standard deviation, frequence as
percentage and non-normally distributed data as me-
dian and interquartile range (IQR). Data were com-
pared for statistical significance using t-test, χ2 or
Mann-Whitney tests as appropriate. Multiple compar-
isons of HrQoL scores over time were carried by
ANOVA with Friedmann test.
Table 1 Demographic Data (n = 125) (Continued)
Dizziness 32 (26.0 %) 17 (27.4 %) 15 (24.6 %) .72
Fatigue 62 (50.4 %) 31 (50.0 %) 31 (50.8 %) .93
Other complaints 12 (9.8 %) 5 (8.1 %) 7 (11.7 %) .50
Operative data (N = 125)
Coronary Artery Bypass Grafting 39 (31.2 %) 23 (36.5 %) 16 (25.8 %)
Valve replacement 50 (40.0 %) 24 (38.1 %) 26 (41.9 %) .11
CABG and Valve replacement 28 (22.4 %) 15 (23.8 %) 13 (21.0 %)
Other cardio-surgery 8 (6.4 %) 1 (1.6 %) 7 (11.3 %)
Abbreviations: SR Sinus Rhythm, AF Atrial Fibrillation, COPD Chronic obstructive pulmonary disease, CABG Coronary artery bypass graft
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A generalized linear model (GLM) was employed to
study the the effect of conversion to SR at 12 months as
well as other categorical predictors (factors) or continu-
ous predictors (covariates) on HrQoL. More specifically,
six composite HrQoL outcomes were defined : the two
SF-36 composite scores (PCS and MCS), the VAS score,
two EuroQoL composite scores (one mental score
[EuroQoL-MS] including anxiety/depression and self-
care and one physical [EuroQoL-MS] with mobility,
usual activities and pain/discomfort) and two MFI20
Fig. 1 SF-36 subscales in patients with or without recurrent arrhythmia at 12 month-follow-up. * Significance between follow-up steps.≠ Inter-group
significance significance
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composite scores (one mental score [MFI20-MS] includ-
ing Mental Fatigue and Reduced Motivation and one
physical [MFI 20-PS] with General Fatigue, Phisical Fa-
tigue, and Reduced Activities).
All these outcomes showed a skewed distribution
using histograms paneled by single outcome. The follow-
ing variables were entered as potential predictors into
the model: preoperative (age, gender, type of AF, AF dur-
ation, left atrial dimension, left ventricular ejection frac-
tion, myocardial infarction,hypertension, diabetes, renal
disease, chronic obstructive pulmonary disease, renal in-
sufficiency) intraoperative (coronary artery bypass graft-
ing, valve replacement, associated intervention,other
cardiac surgery) and postoperative (SRD, SR3, SR6, SR12).
On the basis of our previous experience [7] we created
four new categorical variables (0/1) in the dataset: fe-
male sex, age ≥ 65 years, AF duration ≥12 months and
type of AF > paroxysmal. We choosed a γ distribution
with a log-link function on the basis of the best
goodness-of-fit and the type III analysis. The Wald χ2,
the exp(β)-Odd ration and the 95 % Wald confidence for
exp(β) were reported.
SPSS v.18.0 (IBM Corp., Armonk, NY, USA) was used
for analysis and a p value <0.05 was considered to indi-
cate statistical significance.
Results
Patient characteristics and rhythm follow up
Seven patients died during the 12 months follow up
therefore a total of 125 patients were taken into account
for analysis. Among them, sixty-two (47 %) were in SR
sinus rhythm at 12 months follow up whereas 63 (53 %)
had recurrent arrhythmia. Table 1 dysplays patients
characteristics. Subjects who were not in SR at
12 months had larger atria (p < 0.001) and an higher per-
entage of patients with permanent AF (<0.001). No other
difference was detected between groups.
Morbidity and mortality
No significant differences were found between SR-group
and non-SR-group regarding the number of rethoraco-
tomies (p = 0.56), pulmonary complications (p = 0.07),
myocardial infarction (p = 0.23), renal failure (p = 0.84),
stroke (p = 0.38), wound infections and other infections
(p > 0.9), hours of ICU stay (p = 0.09) and total hospital
stay in days (p = 0.11).
Effect of Add-on surgery on HrQoL
SF-36
Figure 1 shows the comparison in SF-36 domains be-
tween patients with or without AF at different times. At
baseline SF-36 scores were comparable between Groups.
All subscales of SF-36 improved at 3 months in patients
without arrhythmia. In contrast, in patient with
recurrent arrhythmia BP, GH, PF an Vt which improved
fronm baseline (p < 0.05), MH, RE, RF and SF worsended
from baseline (all, p < 0.01). The latter domains were sig-
nificantly lower in patient with recurrent AF (p < 0.05).
At 6 months no significant variation was detected in
both groups in SF- scales with intergroup-differences in
MH, RE, RF and SF remaining unchanged (all, p < 0.01).
Finally, at 12 months, only SF and GH further Im-
proved in patients in SR. In patients with AF Mental
Health, RE and SF worse than in patients with no-AF. In
contrast RP improved and was not significantly different
compared to AF patients.
Finally Physical composite score was not significantlty
different between groups whereas mental composite
score was significantly higher in patients without AF
recurrence (Fig. 2).
EuroQoL
Compared with baseline, EQ-5D and EQ-VAS improved
significantly at 12 months either in patients with SR
(61.2 ± 11.3 vs. 74.0 ± 12.8, p < 0.001 and 67.5 ± 10.9 vs.
71.0 ± 12.0, p = 0.004) or those with AF (61.3 ± 10.7 vs.
71.0 ± 12.3, p = 0.003 and 68.1 ± 10.3 vs. 72.0 ± 11.4, p =
0.02) with no significance between Groups (p = 0.06 and
p = 0.79 for EQ-5D and EQ-VAS, respectively.
Fig. 2 SF-36 subscales Composite Scores. in patients with or without
recurrent arrhythmia at 12 month-follow-up. * Significance between
follow-up steps.≠ Inter-group significance significance
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Figure 3 shows that no difference was found in any
EQ-5D sub-domains at 3, 6 or 12 months.
MFI-20
At 3 months, changes in GF, PF and RA were not signifi-
cant in both group with any difference detected between
patients with or without AF recurrence (Fig. 4). In con-
trast, in patients no in sinus rhythm MF and RM were
significantly lower compared to baseline (p = 0.004) and
to no-AF patients (p < 0.001). At 6 months and
12 months MF and RM did not improve in patient with
AF and both these domains were significantly higher
than SR patients (p < 0.001 at 6 and 12 months). No
other relevant changes were detected in patients in SR at
6 and 12 months.
Relationship between 12-month SR and HrQoL
Results of GLM are shown in Table 2. Synus rhytm at
12 months was independent predictor of SF36-MS. Age
<65 years and preoperative AF duration <12 months
were also significant. SR12 also predicted Euro-QoL-MS
(with paroxysmal type of AF), VAS and MFI 20-MS.
In contrast, SR12 was not significant for SF36-PS,
Euro-QoL-PS and MFI20 –MS (all, p > 0.05).
On the contrary SF36-PS was predicted by age <65 years,
Euro-QoL-PS by age <65 years and paroxysmal type of AF
whereas MFI 20-PS by age <65 years, paroxysmal type of
AF and preoperative AF duration <12 months. SR3 and
SR6 resulted to be not significant.
The subanalysis of the influence of SR12 according to
the presence –absence of other cofactors showed that
patients in SR at 12 months were associated with in-
creased HrQoL regardless of age, preoperative AF dura-
tionand type of AF. There were no apparent significant
interactions between SR12 and any of the covariates
(Fig. 5).
Discussion
At the best of our knowledge, this is the first study
to explore the relationship between manteinance of
sinus rhythm 12 months after surgical ablation (SR12)
associated to other cardiac procedures (add-on sur-
gery) and health-related quality of life (HrQoL). The
purpose of the present report was to measure the im-
pact and the predictive value of SR12 on subscales of
three different HrQoL questionnaires: SF-36, EuroQoL
and MFI 20.
The main findings of our study can be summarized as
follows: First, sinus rhythm at 12 months was predictive
of improvement of SF36-MS, Euro-QoL-MS, VAS and
MFI 20-MS. Furthermore, when we allowed for inter-
action between type SR12 and other significant risk fac-
tors (age <65 years, paroxysmal type of AF and
preoperative AF duration <12 months) we found that
the effect of SR12 on SF36-MS, Euro-QoL-MS, VAS and
MFI 20-MS was similar or even higher in low- versus
high-risk- patients. Moreover, we failed to find any sig-
nificant interactions between SR12 and any of the other
risk factors demonstrating that SR12 remains a critical
determinant of these HrQoL outcomes beyond any other
potentially associated predictor.
It has been demonstrated that the impact of AF on
HrQoL extends beyond symptoms. Indeed, the psycho-
logical and emotional effects of AF can be debilitating
and several limited studies suggest that psychological
distress may be linked with patient-reported AF symp-
tom severity [12] and that patients with AF have a high
prevalence of anxiety and depression [13, 14]. Further-
more, symptoms of depression and anxiety have been
shown to be strong predictor of worsened quality of life
[15, 16] and worsened outcomes [17–20] in patients
with AF. However, there are limited data on the associ-
ation fo SR manteinance and psychological status. Our
study demonstrated the important influence of SR on
HrQoL-mental scores regardless of which specific scale
was used. In other words,in case of recurrent AF after
Table 2 Parameters estimates
Wald χ2 p Exp β 95 % CI Exp β
SF 36 –MS
SR12 9.235 0.021 0.892 0.753–0.995
Age < 65 yrs. 7.818 0.018 1.211 1.098–1.431
AF duration < 12 months 8.190 0.019 0.965 0.801–1.104
SF 36 –PS
Age < 65 yrs. 6.542 0.029 1.156 0.945–1.301
Euro QoL-MS
SR12 8.221 0.009 0.788 0.589–0.873
AF Paroxysmal 10.234 0.005 1.167 0.902–1.298
Euro QoL-PS
Age < 65 yrs. 7.892 0.017 1.115 0.953–1.199
AF Paroxysmal 10.003 0.004 1.056 0.862–1.189
Euro QoL-VAS
SR12 9.776 0.006 0.876 0.678–0.942
AF Paroxysmal 9.993 0.008 1.055 0.899–1.178
MFI 20-MS
SR12 8.569 0.009 1.188 0.976–1.244
Age < 65 yrs. 7.908 0.016 1.045 0.932–1.177
MFI 20-PS
Age < 65 yrs. 9.044 0.019 1.266 1.088–1.399
AF Paroxysmal 9.302 0.020 0.877 0.745–0.978
AF duration < 12 months 8.805 0.015 0.915 0.802–1.105
Abbeviations: CI Confidence Interval, MS Mental Score, PS Physical Score, AF
Atrial Fibrillation
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surgery, psychological comorbidities may heavily influ-
ence healthcare consumption. This aspect warrants
further larger studies.
Second, SR12 was not significant in predicting SF36-
PS, Euro-QoL-PS and MFI20 -PS (all, p > 0.05).
Our findings are in accordance with data from a
recent reasearch [21] showing that patients who main-
tained sinus rhythm after ablation had a significant
improvement in AF symptoms and HrQoL whereas no
improvement was observed in patients with recurrent
AF.
Prior studies for largely paroxysmal AF treated with
catheter ablation showed a significant post-ablation
amelioration of HrQoL, with the benefit lasting over
2 years [22, 23]. Furthermore, Fiala et al [24] found a
significant rise in QoL after catheter ablation of long-
standing persistent AF at 1 year that further slightly
increased at 2 years. Nonetheless, these authors, unlike
for functional benefits, were not able to demonstrate a
significant difference between SR and non-SR subgroups
at 1 year when modest HrQoL improvement was also
present in patients examined in AF/AT.
Third, in our experience SF36-PS was predicted by age
<65 years, Euro-QoL-PS by age <65 years and paroxys-
mal type of AF whereas MFI 20-PS by age <65 years,
paroxysmal type of AF and preoperative AF duration
<12 months.
It is not surprising that patients with AF > paroxysmal
show worse physical HrQoL subscales but it is interest-
ing that SR12 was not predictive of pysical improvement
despite patients in AFat 12 months a significantly higher
percentage of pemanent AF patients (48.4 % vs. 17.5 %).
Fig. 3 EQ-5D sub-domains and VAS score in patients with or without recurrent arrhythmia at 12 month-follow-up. * Significance between
follow-up steps.≠ Inter-group significance significance
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This suggest that the AF type is a primary predictor and
it is not strenghten by the postoperative rhytm. This was
confirmed by the not significant interaction between the
two variables (p = 0.44).
Regarding age,as we might expect, ≥ 65 years
showed a worse HrQoL after surgery. However, it
must be considered that elderly patients differ consid-
erably from patients in the younger age group as they
have a higher incidence of AF associated with other
risk factors and frequent multiple comorbidities which
may affect their pst-surgery HrQoL. Nonetheless, we
do believe that there is no reason to deny a priory
add- on surgery to elderly since results from the
literature suggest that catheter ablation of AF in
elderly patients can be performed with success rates
comparable to those in younger without an increase
in complication rate [25].
Study limitations
Our study has some limitations which need to be
highlithed.
First of all, this study was performed retrospectively
and this could have significantly affected our results.
Second,we employed an old version and no disease
specific-HrQoL questionnaires. It is well known that
HrQoL outcomes can be weakened by other life events
or physical complaints during follow up. This ‘attenu-
ation’ effect may become even larger as the follow up
period extends.
Fig. 4 MFI-20 sub-domains in patients with or without recurrent arrhythmia at 12 month-follow-up. * Significance between follow-up steps.
≠ Inter-group significance significance
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Conclusions
Specific mental-related HrQoL scales are much more sensi-
tive to sinus rhythm conversion. Sinus rithm mantainance
shows significant effects on mental scores independently of
cofactors such as age, type of AF and AF type. Successful
conversion to sinus rhythm after surgical ablation during
cardiac surgery does not significantly affect phisical health
related quality of life during 1 year follow up.
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